1. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation. Issue 5 (7th September 2016) Authors: Cholongitas, E.; Goulis, I.; Antoniadis, N.; Fouzas, I.; Imvrios, G.; Giakoustidis, D.; Giouleme, O.; Papanikolaou, V.; Akriviadis, E.; Vasiliadis, T. Journal: Transplant infectious disease Issue: Volume 18:Issue 5(2017) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prevalence of hepatitis E in liver transplant recipients in Greece. Issue 13 (5th July 2018) Authors: Sinakos, Ε.; Gioula, G.; Liava, Ch.; Papa, A.; Papadopoulou, E.; Tsakni, E.; Fouzas, I.; Akriviadis, E. Journal: Epidemiology and infection Issue: Volume 146:Issue 13(2018) Page Start: 1619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease. Issue 7 (11th November 2014) Authors: Cholongitas, E.; Vasiliadis, T.; Goulis, I.; Fouzas, I.; Antoniadis, N.; Papanikolaou, V.; Akriviadis, E. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 7(2015) Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗